Clinical trial No longer in our active list Interventional Ages 18 and up

Impact of a wearable monitoring system on detecting patient deterioration

Official title: The Virtual High Dependency Unit (vHDU) Project Phase 5: Impact of an Ambulatory Monitoring System on Deterioration Detection and Clinical Outcomes. A Feasibility Randomised Controlled Trial

Run by University of Oxford · NCT05118477 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new wearable monitoring system can help doctors spot problems earlier in hospitalized patients compared to regular monitoring.

More Bariatric Surgery trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorUniversity of Oxford
Academic / other
Locations1 site (Oxford, Oxfordshire)
Trial IDNCT05118477 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include hospitalized surgical patients who are stable for at least 6 hours and not currently under continuous monitoring.

Probably not a fit

Patients with intra-cardiac devices or those monitored for less than 24 hours may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of an ambulatory monitoring system (AMS) that continuously tracks patients' vital signs compared to standard care in detecting clinical deterioration in hospitalized patients. The trial involves a randomized controlled design with two groups: one using the AMS with active alerts and the other receiving standard monitoring. It aims to assess not only the detection of deterioration but also the overall clinical outcomes, staff impact, and patient experience. Participants will be recruited from surgical wards at Oxford University Hospitals NHS Foundation Trust and will wear monitoring devices throughout their hospital stay.

Why it matters

Potential benefit: If successful, this approach could lead to earlier detection of patient deterioration, potentially improving survival rates and clinical outcomes.

How similar studies have gone: Other studies have shown promise in using wearable technology for patient monitoring, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient stable for at least 6 hours with at least one of the following:

  * NEWS2 \<= 2 and (in some exceptional NEWS \>2 confirmed with clinical staff, eg. patients with comorbidities).
  * Frequency of observations of \>4 hours at the time of randomisation.
* Participant is willing and able to give informed consent for participation in the trial.
* Male or Female, aged 18 years or above.
* Any patient admitted to the participating surgical unit (including post-ICU patients) who are not currently monitored with standard continuous monitoring

Exclusion Criteria:

* The participant may not enter the trial if ANY of the following apply:

  * Intra-cardiac device
  * Monitored for less than 24 hours

Where it's running

  • Oxford University Hospitals Trust
    Oxford, Oxfordshire, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.